Skip to main content
Clinical Trials/NCT06445179
NCT06445179
Recruiting
N/A

Robot-Assisted Versus Standard Laparoscopic Approach of Total Hysterectomy for Deep Infiltrating Endometriosis and Adenomyosis: A Multicenter, Open-label Randomized Controlled Trial

GCS Ramsay Santé pour l'Enseignement et la Recherche2 sites in 1 country224 target enrollmentApril 16, 2025
ConditionsEndometriosis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Endometriosis
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Enrollment
224
Locations
2
Primary Endpoint
Intra and post-operative complication rates
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this study is to compare the robot-assisted approach with the laparoscopic approach in terms of reducing the rates of intraoperative and postoperative complications in patients undergoing total hysterectomy for DIE and adenomyosis without digestive tract involvement.

Detailed Description

The ENDO-RAS trial aims to evaluate the safety and effectiveness of robot-assisted laparoscopy compared to conventional laparoscopy for hysterectomy in patients with Deep infiltrating endometriosis and adenomyosis without digestive tract involvement, as verified by magnetic resonance imaging and classified using both the ENZIAN and Deep Pelvic Endometriosis Index classifications. These classifications are used to evaluate Deep infiltrating endometriosis and reproducibly predict the occurrence of postoperative complications. Eligible patients will be recruited from the gynecological surgery department after meeting the inclusion and non-inclusion criteria and signed informed consent forms. Participants will then be randomly assigned to receive either robot-assisted total laparoscopic hysterectomy or total laparoscopic hysterectomy. The ENDO-RAS Trial is a multicenter, randomized, controlled, and open-label study. Eligible patients will be randomized into two parallel groups.

Registry
clinicaltrials.gov
Start Date
April 16, 2025
End Date
June 1, 2027
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥ 18 years of age.
  • Diagnosed adenomyosis, either internal or external (magnetic resonance imaging) per the Enzian and dPEI classifications.
  • Diagnosed deep infiltrating endometriosis per the Enzian and dPEI classifications, without the involvement of the digestive tract.
  • Failure of first- and second-line medical treatment.
  • Eligibility for total hysterectomy with complete removal of endometriosis lesions.
  • Participants covered by entitled to social security.
  • All participants must provide written informed consent before undergoing the surgical procedure.

Exclusion Criteria

  • Digestive tract involvement.
  • Adenomyosis only.
  • Contraindications to surgery.
  • Participants who are under guardianship, curatorship, or deprivation of liberty.

Outcomes

Primary Outcomes

Intra and post-operative complication rates

Time Frame: 3 months

Rate of intra- and post-operative complications (Clavien-Dindo grade 2 or higher) following surgery (Total Laparoscopic Hysterectomy).

Study Sites (2)

Loading locations...

Similar Trials